A detailed history of Squarepoint Ops LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 33,701 shares of INMB stock, worth $151,317. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,701
Holding current value
$151,317
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.86 - $9.86 $163,786 - $332,291
33,701 New
33,701 $181,000
Q1 2024

May 15, 2024

BUY
$10.53 - $14.01 $141,533 - $188,308
13,441 New
13,441 $157,000
Q1 2023

May 15, 2023

BUY
$6.01 - $10.18 $78,400 - $132,798
13,045 New
13,045 $84,000

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $80.6M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.